Nu Skin Cuts Q3 Revenue Outlook As Delta Variant Disrupts Sales

by Shivani Kumaresan, Benzinga Staff Writer

October 4, 2021 8:30 AM | 1 min read | Make a Comment

Nu Skin Enterprises Inc NUS expects third-quarter revenue of $637 million -$642 million (consensus $710.11 million), down from the previous guidance of $700 million - $730 million.
Nu Skin noted unanticipated government restrictions had impacted its ability to sell and distribute products, with the largest impact in Mainland China and Southeast Asia.
"Our third-quarter revenue was softer than anticipated as the delta variant created unexpected disruptions in many of our markets," said CEO Ryan Napierski.
The company will release full third-quarter results and provide updated guidance after the market closes on November 3, 2021.
Nu Skin anticipates annual 2021 revenue to be up modestly year over year.
Price Action: NUS shares are trading lower by 4.05% at $49.8 in premarket on the last check Monday.

Posted In: News Guidance Movers Trading Ideas Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.